For Carl Icahn and his allies, acquiring 12.6% of Hologic shares gave them enough leverage to start getting their way. As part of an agreement with Icahn, the company added two new independent directors and replaced its CEO.
Irish medical device giant Covidien over the weekend announced a definitive agreement to acquire PillCam maker Given Imaging for $860 million, ending about a year of takeover talk.
European CRO Venn Life Sciences is back at the buyer's table, picking up Ireland's Medevol in a deal worth just over $1 million.
CRO Sarah Cannon Research Institute has acquired Connecticut's Clinical Development Group, a trial consulting outfit with a wide range of offerings in oncology R&D.
Federal agents reportedly carried boxes of documents out of the Reckitt Benckiser headquarters in Virginia on Tuesday. The officials did not disclose the purpose of the warrant.
When Thermo Fisher Scientific announced a $3.2 billion bond offering Wednesday, Fitch Ratings promptly lowered the medical device maker's credit rating to BBB and Moody's Investors Service said it likely will do the same.
It's looking like the end of the line for Transcept Pharmaceuticals: The troubled biotech, long in search of a buyout offer, will be forced to liquidate if it doesn't find a benefactor before the second quarter of next year, the company said.
Mylan's buyout of Agila Specialties from India's Strides Arcolab hit a hitch after the FDA issued a warning letter to one of Agila's plants. Mylan said it was holding back $250 million of the $1.75 billion payout until the regulatory issues get resolved.
The Medicines Company is taking a deep dive into hospital-borne infection treatments, signing a deal worth up to $464 million to pick up Rempex Pharmaceuticals and its fleet of pathogen-fighting drugs.
Boehringer Ingelheim is in the midst of closing down its troubled Ben Venue generic sterile injectables facility in Ohio after deciding it was not worth pouring more money into its rehabilitation. But given that there is growth in generic and contract injectable manufacturing, the German company hopes someone might want to take it off its hands.